50 % of patients involved in clinical trials do not take their medication as prescribed, resulting in underestimated drug efficacy and delayed approval of the investigational product.
Poor medication adherence is thus a threat to drug development.
Stop using unreliable methods to assess medication adherence and maximize the chances of success in your clinical trials by using an evidence-based digital adherence monitoring system.
Back in 1981 Zanussi, the Italian manufacturer of home appliances, launched one of the most iconic marketing slogans ever – ‘The appliance of science’. Aiming to convey the message that Zanussi appliances were built with a high level of engineering
In the early stages of drug development, as the promise surrounding a new therapy builds, there is a palpable sense of the stakes being raised. And when encouraging findings lead to progress on the clinical trial pathway, those stakes are